Showing 6,049 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Access to healthcare

Open Letter: Community Statement on Accelerating Access to Lenacapavir by Gilead

Editor's pick
AfroCAB
18 July 2023
Epidemiology

Late, Delayed ART Initiation in China Significantly Decreased After Guideline Update

Editor's pick
American Journal of Managed Care
18 July 2023
PrEP programmes & uptake

Peer support helps young women in Uganda stay on PrEP

Editor's pick
Be In The Know
14 July 2023
Antibody-based treatment

Broadly neutralizing antibody treatment found to reduce viral reservoir in some infants with HIV-1

Editor's pick
Medical Xpress
12 July 2023
Diabetes

No link between weight gain on integrase inhibitors and diabetes

News
12 July 2023
Recently diagnosed with HIV

ART ‘starter packs’ help link patients to HIV care from emergency department

Editor's pick
Healio
10 July 2023
The search for a cure

Novel drugs that turn HIV against itself might clear infected cells from the body

News
10 July 2023
Treatment outcomes & life expectancy

Life expectancy for people living with HIV

About HIV
July 2023
HIV treatment

Why hunger is driving thousands to abandon the drugs that keep them alive

Editor's pick
The Telegraph
5 July 2023
Injectable & long-acting HIV treatment

The Yin and the Yang of Cabotegravir-Rilpivirine: Part One, the Good News

Editor's pick
HIV and ID Observations
4 July 2023
Bad science & bogus treatments

Despite persistent claims otherwise, there’s plenty of evidence that HIV exists and is sexually transmitted

Editor's pick
Africa Check
4 July 2023
Treatment simplification strategies

Dolutegravir alone maintains HIV suppression in those treated early

News
28 June 2023
Changing treatment

Second-Line Switch to Dolutegravir Noninferior in HIV

Editor's pick
HealthDay News
26 June 2023
Injectable & long-acting HIV treatment

Going Long

Editor's pick
POZ
26 June 2023
Migrants, refugees & displaced people

French study confirms that people with HIV born abroad are less likely to receive integrase inhibitors than those born in France

News
26 June 2023
Bad science & bogus treatments

ANALYSIS: Is HIV/Aids misinformation and denialism on the rise again?

Editor's pick
Africa Check
20 June 2023
Improving HIV care

Same-day viral load test installed in Uganda, but people with HIV still received results months later

News
20 June 2023
Weight gain & lipodystrophy

HIV and Weight Stigma

Editor's pick
Infectious Disease Special Edition
19 June 2023
Infant feeding

Breastfeeding and HIV in the US and Canada: no transmissions, no consistency

News
19 June 2023
TB treatment

Once-daily dolutegravir sufficient when taking TB treatment

News
16 June 2023
Adherence

Social Determinants Affect Viral Suppression Disparities in Women

Editor's pick
TheBodyPro
15 June 2023
Drug interactions & pharmacokinetics

Can testing for drug-gene interactions improve treatment success in people with HIV?

News
15 June 2023
HIV treatment

Ibalizumab (Trogarzo) Detailed information

About HIV
June 2023
Pregnancy and vertical transmission

Dolutegravir-Based ART Recommended in Pregnancy, Postpartum Period

Editor's pick
Infectious Disease Advisor
9 June 2023